SHARE

News Alert: Citius Pharmaceuticals Receives FDA Approval For LYMPHIR™ (Denileukin Diftitox-Cxdl) Immunotherapy For The Treatment Of Adults With Relapsed Or Refractory Cutaneous T-Cell Lymphoma. Click to Read More.

Lifelogger Technologies Corp (OTCMKTS:LOGG) has landed into quite a lot of trouble after soaring high in the market in the past month. Essentially, the company focuses on wearable video and software technology. Although investors have shown considerable interest towards the industry in general, the same cannot be said about the company’s products. The problem for Lifelogger seems to lie in its management. The company has repeatedly set deadlines for product launches, which it has failed to meet.

Recently, Lifelogger announced that it was working with a leading electronics company to produce a wearable camera. The developments also include upgrades to its cloud system, to store and retrieve those videos when needed. Unfortunately, it seems as the company would miss the deadline of 1Q2015, which it has set for the products launch. Additionally, the company has spent $118,000 on R&D, but still has no patents to show for it.

Currently, the company is valued at $40 million, with a depleting cash reserve. Some analysts even doubt that the company would be able to make it past this year. As per the 10Q filed by the company recently, Lifelogger Technologies Corp (OTCMKTS:LOGG) generated 0 revenues and $290,000 operating loss. The loss itself is overwhelming, given that at the end of March 31, the company only had $81,000. Further investigation revealed that the company has been issuing stock to vendors at $0.20, for their services.

With the 1Q2015 already released, the company still does not have its wearable body camera in the market yet. Unfortunately, there have been no patent filings either, which could very well mean further losses. As per the 1Q2015, the company still has $81,117 in cash, which means that they have been liquidating the stock quite a lot to pay for operating expenses. This is something that is leading the company towards increased losses.

SHARE
Previous articleMedical Marijuana Inc (OTCMKTS:MJNA) Faces Anti-Slapp Motion In Return to its $100 million Lawsuit
Next articleCGrowth Capital Inc (OTCMKTS:CGRA) Reaches A Lease Agreement with Wildfire For Washington Properties
Steve Kanaval: Portfolio Manager/Writer/ Market Analyst Steve began his career in the Trading Pits in Chicago making markets at the Chicago Mercantile Exchange (NYSE:CME) the Chicago Board of Trade and the CBOE in the early 80’s. He ran the Morgan Stanley Derivative Prop Trading for the firm specializing in Index Arbitrage. He continued his career as a Trader/Portfolio Manager for multiple Hedge Funds during the Internet Boom of the 90’s managing large portfolios. Steve is known as an expert in MicroCap Technology Stocks and the emerging Digital Currency markets as a Portfolio Manager for his Family Office. Steve has managed portfolio’s in volatile asset classes for 3 decades as a commodity trader, hedge fund manager and digital currency trader and miner. Steve publishes his views on the asset classes in a public forum and has published more than 10,000 articles simplifying these complex and volatile assets for readers. His work is published on multiple sites including Bloomberg, Equities.com, Hacked.com, CryptoCurrencyNews as a paid contributor. His work includes research, journalism and archived video on important market volatility related to stocks, digital currency and other volatile misunderstood asset classes. He offers a humorous, unique insight and the related back stories and drivers for readers interested in volatility and emerging market assets. Full disclosure Steve is long 25 digital currencies and sits on the board of multiple public companies involved in digital currencies, and owns shares in these companies from time to time.